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It has been widely accepted that macrophages are divided into M1 “pro-inﬂammatory” macrophages and
M2 “anti-inﬂammatory” macrophages and an uncontrolled macrophage polarization plays an important
role in the pathogenesis of different diseases. As the main substance of total glucosides of peony,
paeoniﬂorin (PF), has been widely used to treat autoimmune and autoinﬂammatory diseases for years.
Mechanistically, PF has been found to alter activities of many immune cells, which could further reduce
inﬂammation and tissue damage. However, whether and how PF affects macrophages activities in vitro
remains unknown. In current study, using M1 and M2 cells generated from mouse bone marrow pre-
cursors, we explored the role of PF in regulating M1/M2 cells activity in vitro. The results showed that PF
inhibited LPS-induced M1 activity by reducing iNOS expression and NO production via decreasing LPS/
NF-kB signaling pathway; whereas, PF enhanced IL-4-provoked M2 function by up-regulating Arg-1
production and activity via increasing IL-4/STAT6 signaling pathway. Our new ﬁnding indicates that PF
can suppress M1 cells activity and enhance M2 cells function simultaneously, which could help to
ameliorate autoimmune and autoinﬂammatory diseases in clinical treatment.
© 2016 Japanese Pharmacological Society. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Macrophages, as ﬁrst identiﬁed immune cells, play critical roles
in both innate and adaptive immune responses and classiﬁed into
two types according to their functions (1,2). Type I macrophages
(M1) are marked by producing large amounts of pro-inﬂammatory
mediators such as TNF-a, IL-6, IL-23, IL-12 and generating reactive
oxygen species such as NO via activation of inducible nitric oxide
synthesis (iNOS) (3), whereas type II macrophages (M2) release
high levels of anti-inﬂammatory molecules such as IL-10, and can
be deﬁned based on a speciﬁc genetic signature characterized by
the upregulation of Ym1 (also known as Chil3l3) and FIZZ1 (also
known as Retnla) genes (4). Additionally, arginase-1 (Arg-1)munology & Department of




. Production and hosting by Elseproduction is increased in M2-polarized macrophages, which in
turn blocks iNOS activity by a variety of mechanisms (5). It is well
known that, an uncontrolled macrophage polarization plays an
important role in the pathogenesis of many autoinﬂammatory
diseases, for example, excessive M1 polarization in adipose tissues
is linked to metabolic disease (6). Moreover, the distribution of M1
and M2 polarization in human atherosclerosis shows to be related
with plaque instability (7). In dextran sodium sulfate (DSS)-induced
murine experimental colitis, increased M1 cells and decreased M2
cells are associated with the disease progress (8). All these evi-
dences indicate that the balance of M1 and M2 cells is crucial for
homeostasis and re-balancing the proportion of M1/M2 might be
the potential therapy of autoimmune and autoinﬂammatory
diseases.
Paeoniﬂorin (PF), one of the major bio-active components of
Paeony root, has been widely used as an anti-inﬂammation and
immunomodulatory agent in diverse autoimmune diseases such as
rheumatoid arthritis (RA), psoriasis, sj€ogren's syndrome (SS) and
systemic lupus erythematosus (SLE) (9e11). It was reported that, PF
inhibits T and B cells proliferation in arthritis animal model (12),vier B.V. This is an open access article under the CC BY-NC-ND license (http://
T. Zhai et al. / Journal of Pharmacological Sciences 130 (2016) 143e150144up-regulates the regulatory T cells (Treg) function in SLE patients
and SS animal model (9,13). Our previous study showed that PF
decreased maturation of dendritical cells (DCs) in CIA mice (14),
reduced the number of F4/80þCD68þ macrophages in imiquimod
(IMQ)-induced psoriasis-like mice (15). Besides, in vitro study, we
found that PF inhibited the functions of B cells stimulated by LPS
(16). Although PF has been found to alter activities ofmany immune
cells, whether and how PF regulates M1 and M2 cells activities
in vitro remains unknown.
In this study, we treated mouse bone marrow derived M1 and
M2 cells with PF and found that PF reduced M1 cells activity
stimulated by LPS through inhibiting the activation of NF-kB
signaling pathway, meanwhile, PF enhanced M2 cells function
provoked by IL-4 via activating STAT6 phosphorylation. Consid-
ering the critical roles of macrophages played in inﬂammatory and
autoimmune diseases, to learn the effect of PF involved in regu-
lating M1 and M2 cells activation will give a new insight into the
therapeutic treatment. Taken together with our previous works,
this study supplies that PF is beneﬁt for not only Th1/Th17 or B
cells-associated inﬂammation and autoimmune diseases, but also
macrophage-associated diseases, providing solid evidence to the
wide use of PF in clinical treatment.
2. Material and methods
2.1. Drugs
PF (molecular weight 480.05), supplied from Liwah Plant extract
technology Co. Ltd. (Ningbo, China), was dissolved in double
distilled water and ﬁltrated. 1, 10, 100 mg/ml PF were used in this
study.
2.2. Animals
Male 6e8w Balb/c mice were purchased from the Shanghai
Laboratory Animal Center, Chinese Academy of Science (Shanghai,
China). The mice were maintained under pathogen-free conditions.
All of the experiments were performed according to the Animal
Care and Use Committee guidelines.
2.3. M1 and M2 macrophages generation and identiﬁcation
Bone marrow precursor cells were collected from 6-8w male
Balb/c mice and cultured in RPMI 1640 medium containing 10%
heat-inactivated fetal bovine serum (FBS), 100 mg/ml streptomycin,
100 units/ml penicillin and 2 mM L-glutamine (Gibco, New York,
USA). 20 ng/ml recombinantmurine GM-CSF (PeproTech Inc., Rocky
hill, USA) and 50 ng/ml recombinant murine M-CSF (PeproTech)
were added to the medium respectively for M1 and M2 polariza-
tion. After 7 days, the morphology of M1/M2 cells was observed by
light microscope. Generated M1/M2 cells were stained with anti-
mouse F4/80, CD11b and CD11c (eBioscience Inc., California, USA)
antibodies. Flow cytometry was performed using FACS Calibur cy-
tometer (BD Biosciences) and analyzed by FlowJo7.6 software
(Treestar Inc., California, USA). The adherent M1 and M2 cells were
treated with 100 ng/ml lipopolysaccharide (LPS, Sigma, Missouri,
USA) and 20 ng/ml murine IL-4 (PeproTech) for 24 h respectively
according to previous reports (17,18), then the mRNA proﬁles of
activated M1 and M2 cells were examined by real-time PCR.
2.4. Cell viability assay
Cell viability was examined using a Cell Counting Kit-8 (CCK-8,
Dojindo, Mashikimachi, Japan) according to manufacturer'sinstructions as previous reports (16,19) (Supplementary material
and methods 1).
2.5. RNA extraction and real-time PCR
Bone marrow precursor cells cultured with GM-CSF (20 ng/ml)
or M-CSF (50 ng/ml) for 6 days to induce M1 or M2 cells, then
different concentrations of PF (1, 10 and 100 mg/ml) were added for
24 h before stimulating these cells with LPS (100 ng/ml) or IL-4
(20 ng/ml) respectively for another 24 h. RNA extraction and real-
time PCR were performed as previously reported (20)
(Supplementary material and methods 2). Primers were designed
using Primer Express 3.0 software (Applied Biosystems) and shown
in Table 1.
2.6. Western blotting analysis
Bone marrow precursor cells cultured with GM-CSF (20 ng/ml)
or M-CSF (50 ng/ml) for 6 days to induce M1 or M2 cells, then
different concentrations of PF (1, 10 and 100 mg/ml) were added for
24 h before stimulating these cells with LPS or IL-4 respectively.
Cells were harvested and lysed. Speciﬁc antibodies to iNOS, Arg-1,
total STAT6, total and phosphorylated NF-kB p65 were purchased
from Cell Signaling Technology Inc. (Massachusetts, USA). Anti-
bodies to phosphorylated STAT6 were purchased from Santa Cruz
Biotechnology Inc. (Dallas, USA). The Gel-Pro Analyzer 4 (Exon-
Intron Inc., Loganville, USA) was used to analyze bands density. The
alteration of target proteinwas displayed as relative fold which was
derived from comparisonwith b-actin or their non-phosphorylated
counterparts.
2.7. NO production assay
M1 cells pre-treated with PF for 24 h were subsequently stim-
ulated with LPS. NO production in M1 cells was assessed using NO
assay kit (Beyotime, China) following the manufacturer's in-
structions. Brieﬂy, the supernatant of cultured cells was mixed with
an equal volume of Griess reagent (1% sulfanilamide, 0.1% naph-
thylethylenediamine dihydrochloride, and 2.5% phosphoric acid)
and incubated at room temperature for 5 min. The concentration of
nitrite was measured by reading at 570 nm absorbancewavelength.
Sodium nitrite (NaNO2) was used as a standard curve.
2.8. Arg-1 activity assay
M2 cells pre-treated with PF for 24 h were subsequently stim-
ulated with IL-4. Arg-1 activity in M2 cells was assessed by an
Arginase Assay Kit (Abnova, Taipeh, Taiwan), following the manu-
facturer's instructions (Supplementary material and methods 3).
2.9. Immunoﬂuorescence analysis
M1/M2 cells grown on glass coverslips were treatedwith H2O or
PF for 24 h and then exposed to LPS/IL-4 for 0 or 15 min and ﬁxed
with 4% paraformaldehyde for 20 min. After permeabilizing with
0.3% Triton X-100 (Sigma, MO, USA) in PBS, cells were blocked with
10% normal goat serum (Cell Signaling Technology Inc.) for 1 h.
Anti-NF-kB p65/anti-STAT6 antibody was applied at dilution ratio
of 1:200 at 4 C overnight. After washing, Alexa Fluor 488/594-
conjugated anti-rabbit IgG (Cell Signaling Technology Inc.) were
used as secondary antibody at 1:1000 dilution for 1 h at room
temperature. Nuclei were counterstained with 0.25 mg/ml of 4-, 6-
diamidino-2-phenylindole (DAPI; ZyMed, CA, USA) for 3 min.
Coverslips with antifade ﬂuorescent mounting medium were
transferred onto glass slides. NF-kB p65/STAT6 nuclear
T. Zhai et al. / Journal of Pharmacological Sciences 130 (2016) 143e150 145translocation in M1/M2 cells were studied with the confocal laser
scanning ﬂuorescence microscopy (LSM510; Zeiss, Jena, Germany)
technique as described previously (20).2.10. Statistical analysis
All experiments were performed in triplicate. The difference
among groups was determined by ANOVA analysis and comparison
between two groups was analyzed by the t-test using the GraphPad
Prism 5.0 (GraphPad Software Inc., California, USA). A value of
P < 0.05 was considered as statistical signiﬁcance.Fig. 1. Identiﬁcation of M1 and M2 cells generated from mouse bone marrow precursor cells
line) were estimated by ﬂow cytometry. (B) mRNA proﬁles of M1 and M2 cells stimulated by
mean ± SEM of at least three independent experiments. **P < 0.01, ***P < 0.001.3. Results
3.1. Generation and identiﬁcation of M1 and M2 cells in vitro
To explore whether PF affects the activities of M1 and M2 cells,
we ﬁrst generated and identiﬁed these two type macrophages. The
results showed that adherent cells exhibited typical morphology
after 7 days culture in accordance with previous reports (21): M1
cells displayed a rounded morphology, while M2 cells appeared
elongated and spindle-shaped morphology (data not shown). Next,
we examined the surface markers by ﬂow cytometry. The results
showed that more than 90% of generated cells were F4/80þCD11bþ. (A) F4/80þCD11bþCD11cþM1 cells (blue line) and F4/80þCD11bþCD11cM2 cells (red
LPS and IL-4 respectively were detected by real-time PCR. The results are expressed as
Fig. 2. PF had no effect on the viability and activity of un-stimulated M1 and M2 cells in vitro. M1 or M2 cells were treated with (black bar) or not (open bar) different concentrations
of PF. (A) Cell viability was measured by the CCK-8 assay. (B) The mRNA expression of iNOS in M1 cells and Arg-1 in M2 cells was examined by real-time PCR. The results are
expressed as mean ± SEM of at least three independent experiments.
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uniquely expressed on M1 cells. The results showed that GM-CSF
induced cells are F4/80þCD11bþCD11cþ M1 cells (Fig. 1A, upper
panel), and M-CSF induced cells are F4/80þCD11bþCD11cM2 cells
(Fig. 1A, lower panel). Further, we examined the activity of gener-
ated M1 and M2 cells stimulated by LPS and IL-4 respectively. The
results showed that LPS stimulated M1 cells expressed high levels
of iNOS, IL-12, IL-23 and TNF-а (Fig. 1B, left panel), and IL-4 acti-
vated M2 cells expressed high levels of Arg-1, Fizz-1 and YM-1
(Fig. 1B, right panel). These data indicated that we generated
typical M1 and M2 cells successfully in vitro.
3.2. PF has no effect on un-activated M1 and M2 cells in vitro
Next, we studied the effect of PF on the viability and activity of
un-stimulated M1 and M2 cells. The results showed that PF did not
affect either the M1 or M2 cells viability (Fig. 2A) or the expression
of the iNOS mRNA in M1 cells and the Arg-1 mRNA in M2 cells
(Fig. 2B), indicating that PF did not alter the viability and activity of
un-stimulated M1 and M2 cells.
3.3. PF impaired the activity of M1 cells stimulated by LPS
It is well known that LPS-induced M1 cells produce high levels
of pro-inﬂammatory cytokines (22), we future explored the effects
of PF on LPS-stimulated M1 cells. The results showed 1 mg/ml of PF
did not show inhibitory effect, but 10 and 100 mg/ml of PF reduced
the iNOS mRNA expression (Fig. 3A). Subsequently, we examined
the NO production and iNOS protein expression in LPS-stimulated
M1 cells upon PF treatment. The results showed both 10 and
100 mg/ml of PF inhibited NO (Fig. 3B) and iNOS protein production
(Fig. 3C). These data suggested that PF indeed decreased LPS-stimulated M1 cells activity by inhibiting iNOS expression at both
mRNA and protein levels in a dose dependent manner.3.4. PF enhanced activity of IL-4-inducing M2 cells
M2 cells show the opposite function of M1 cells in inﬂammatory
and autoimmune diseases (1,2). As we had found that PF could
reduce M1 activity, we next tested the potential effect of PF on M2
activity. The results showed that 10 mg/ml and 100 mg/ml of PF
enhanced Arg-1 mRNA expression (Fig. 4A). Consistently, we found
that 10 mg/ml and 100 mg/ml of PF up-regulated the Arg-1 activity
(Fig. 4B) and protein expression (Fig. 4C), indicating that PF indeed
increased IL-4-activated M2 cells function by promoting Arg-1
production in a dose dependent manner.3.5. PF inhibited NF-kB signaling pathway in LPS-stimulated M1
cells
Previous studies have identiﬁed that NF-kB pathway links to the
LPS-inducedM1 activation (23).We thus examined the alteration of
NF-kB signaling pathways in PF-treated M1 cells. Using western
blotting assay, we found that PF inhibited NF-kB p65 phosphory-
lation in M1 cells dramatically compared with PF-untreated cells
after incubation with LPS for 15 min (Fig. 5A). Consistently, the
immunoﬂuorescence analysis showed that PF reduced LPS stimu-
lated NF-kB p65 translocation into the nucleus of M1 cells (Fig. 5B),
suggesting that NF-kB is the major signal in LPS-provoked M1 cells
affected by PF, which is consistent with our previous reports
(14,16).
Fig. 3. PF inhibited iNOS and NO production in LPS-induced M1 cells. M1 cells were cultured in the absence or presence of PF and subsequently stimulated with LPS (100 ng/ml).
Open bar represented cells without LPS and PF treatment. Grey bar meaned that cells were only treated with LPS. Black bar represented that cells were treated with LPS and PF. (A)
mRNA expression of iNOS was detected by real time PCR. (B) NO levels in the cell culture supernatant were measured by Griess reagent kit. (C) iNOS protein expression was
evaluated by western blotting (left panel). The relative fold of alterated iNOS was calculated and displayed (right panel). Data are expressed as mean ± SEM of three independent
experiments. *P < 0.05, **P < 0.01, ***P < 0.001.
Fig. 4. PF enhanced IL-4-induced Arg-1 activity and expression in M2 cells. M2 cells were stimulated with IL-4 (20 ng/ml) in the absence or presence of PF. Open bar represented
cells without IL-4 and PF treatment. Grey bar represented that cells were only treated with IL-4. Black bar meaned that cells were treated with IL-4 and PF. (A) Arg-1 mRNA
expressionwas examined by real-time PCR. (B)Arginase activity in cell lysate was determined by Arginase activity assay kit. (C) Arg-1 protein was evaluated by western blotting (left
panel). The relative fold of alterated Arg-1 was calculated and displayed (right panel). Data are expressed as mean ± SEM of three independent experiments. *P < 0.05, **P < 0.01.
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Fig. 5. Signaling pathway involved in PF alleviated M1 cell activity stimulated by LPS. (A) M1 cells were stimulated with LPS in the presence or absence of PF for 5 min and 15 min.
NF-kB phosphorylation was analyzed by western blotting and the altered phosphorylation of NF-kB was displayed as relative fold which was derived from comparison with their
non-phosphorylated counterparts. Data are expressed as mean ± SEM of three independent experiments. **P < 0.01. (B) Nuclear translocation of NF-kB in M1 cells was monitored by
confocal ﬂuorescence microscopy. Top panels, Unstimulated M1 cells; Center panels, M1 cells stimulated with LPS for 15 min; Bottom panels, PF-pretreated M1 cells stimulated with
LPS for 15 min. NF-kB p65 was detected by Alexa Fluor 488-anti-p65 (green); Nuclei were stained with DAPI (blue). Merged pictures show NFekB translocation into the nucleus.
Original magniﬁcation 400. Bar, 10 mm. Data represent one of three independent experiments.
T. Zhai et al. / Journal of Pharmacological Sciences 130 (2016) 143e1501483.6. PF activated STAT6 signaling pathway in IL-4-activated M2
cells
Given that STAT6 pathway is related with IL-4-induced M2
activation (24), we examined whether STAT6 was involved in the
function of PF-treated M2 cells. First, we performed the western
blotting experiments and the data showed that PF increased STAT6
phosphorylation dramatically in M2 cells after stimulation with IL-
4 for 5 min (Fig. 6A). To further corroborate the result, we examined
the nuclear translocation of STAT6 in PF-treated M2 cells by laser
scanning confocal immunoﬂuorescence microcopy. The result
showed that PF enhanced STAT6 nuclear translocation in activated
M2 cells (Fig. 6B).
4. Discussion
Macrophages, mainly classiﬁed into M1 and M2 phenotypes, as
ﬁrst identiﬁed immune cells, play critical roles in both auto-
inﬂammatory and autoimmune diseases. It is believed that a switch
in the M1/M2 balance is involved in maintaining tissue homeo-
stasis, and once the balance is broken, immune-mediated inﬂam-
mation and tissue damage occur (6e8). As an extract from the root
of Paeonia lactiﬂora, PF has been widely used to treat autoimmune
diseases, including macrophage associated diseases (9,12). In this
study, using M1 and M2 cells generated from mouse bone marrow
precursors, we found that PF inhibited the activity of LPS-inducedM1 cells by reducing iNOS/NO production but enhanced IL-4-
provoked M2 cells function via upregulating Arg-1 expression
and activity. Further analysis showed that PF impaired LPS/NF-kB
signaling pathway in activated M1 cells but enhanced IL-4/STAT6
signaling pathway in M2 cells.
It is reported that M1macrophages drive the recruitment of Th1
cells through producing cytokines, thereby amplifying the pro-
inﬂammatory response in autoinﬂammatory and autoimmune
diseases (25). For example, in rheumatoid arthritis patients, over-
active M1 cells produce abundant M1 cytokines (TNF-a, IL-1b and
IL-12) and accelerate the development of the disease (26). Besides,
excessive M1 polarization in adipose tissues is linked to metabolic
disease (27). Furthermore, macrophages accumulate in lesional
skin in psoriasis (28) and attenuating macrophage function has
been proposed as an effective strategy for psoriasis treatment (29).
We reported that PF decreased the number and activities of F4/
80þCD68þmacrophages, inhibited production of IL-12 and iNOS in
IMQ-induced psoriasis-like mice (15). In this study, we further
identiﬁed that PF decreased LPS-stimulated M1 cells activity by
inhibiting iNOS expression in a dose dependent manner.
As we know, M1 subset does not produce pro-inﬂammatory
factors in homeostatic state. We found that PF has no effect on
the viability and activity of un-stimulated M1 cells in vitro, which is
consistent with our pervious study: PF has no effect on un-activated
B cells (16). These data revealed that PF selectively inhibited acti-
vated immune cells, which is beneﬁt for the clinical treatment.
Fig. 6. Signaling pathway involved in PF enhanced M2 function provoked by IL-4. (A) M2 cells were stimulated with IL-4 in the presence or absence of PF for 5 min and 15 min.
STAT6 phosphorylation was analyzed by western blotting and the altered phosphorylation of STAT6 was displayed as relative fold which was derived from comparison with their
non-phosphorylated counterparts. Data are expressed as mean ± SEM of three independent experiments. **P < 0.01. (B) Nuclear translocation of STAT6 in M2 cells was monitored by
confocal ﬂuorescence microscopy. Top panels, Unstimulated M2 cells; Center panels, M2 cells stimulated with IL-4 for 15 min; Bottom panels, PF-pretreated M2 cells stimulated
with IL-4 for 15 min. STAT6 was detected by Alexa Fluor 594-anti-STAT6 (red); Nuclei were stained with DAPI (blue). Merged pictures show STAT6 translocation into the nucleus.
Original magniﬁcation 400. Bar, 10 mm. Data represent one of three independent experiments.
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mune response and tissue damage (30), we deduced that PF would
be in favor of M2 activation. Indeed, in this study, we found that PF
could increase IL-4-provoked M2 cells activities by enhancing Arg-
1 production and activity. It is well known that in immune system,
the regulatory subsets play very important role in maintaining
homeostasis and attenuating inﬂammation by producing cytokines
(IL-10, TGF-b) or integrating with target cells directly (31). For
example, regulatory T cells (Treg) are found to inhibit the inﬂam-
mation and immune response in many diseases (32). Accordingly,
increasing the number and activity of these regulatory cells could
be developed as an effective strategy in the treatment of immune
and autoinﬂammatory diseases (33,34). PF has been shown to
promote Treg differentiation and improve Th2 cells function in vivo
(35). It is reported that IL-4-activated macrophages (considered as
M2 cells) were involved in magnifying Treg cells and Th2 cells re-
sponses (25,36). Together with our current study that PF enhanced
the function of IL-4-activated M2 cells, we suggested that PF could
improve the activity of immune regulatory cells widely in vivo and
in vitro. These data showed that PF could suppress M1 cells and
enhance M2 cells activity simultaneously.
What might be the mechanism responsible for the activation of
M1/M2 regulated by PF?
It is believed that a predominance of NF-kB activation contrib-
utes to LPS-induced M1 response (23). LPS, an agonist of TLR4,
cooperating with CD14, initiates innate immunity response and
inﬂammation (37). In our previous studies, PF was found toselectively arrest LPS-induced DC maturation (14), inhibit B cells
activation provoked by LPS but not anti-CD40 or IL-4 (16). In this
study, we ﬁrmly established that PF negatively regulated M1 cells
activity by targeting LPS-induced NF-kB pathway, indicating that PF
could selectively inhibit LPS/TLR4/NF-kB signaling pathway.
Moreover, STAT6 is an important transcriptional factor that plays a
key role in M2 macrophages polarization, and IL-4 can bind to the
complex of the type 1 IL-4 receptors (IL-4Ra) and the common g-
chain (g-c) in M2 macrophages, then the complex receptor system
induces phosphorylation of JAK2, which leads to selective activa-
tion of STAT6, and the phosphorylated STAT6 can translocate into
the nucleus where it binds to the promoter region of target genes,
thereby regulating expression of M2 cells associated genes (38). In
this study, we ﬁrst proposed that PF enhanced M2 cells activity via
promoting IL-4-mediated STAT6 signaling pathway.
In conclusion, our data investigated that PF could suppress M1
and enhanceM2 cells activity simultaneously. Given that numerous
studies have shown that PF shows unique bidirectional function by
bringing dysfunctional immune system back into balance when
treat autoimmune diseases (39), our results provide new insight
into the bidirectional regulatory function of PF, which could be
beneﬁt for autoinﬂammatory and autoimmune disease treatment.Conﬂict of interest statement
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